skip to Main Content

Oxford Vaccine Trials Continue in UK

Oxford announced on Saturday that Clinical Trials will resume in the UK after being halted last Sunday after an unexplained illness emerged in one of its volunteers. According to an Official Press Release, the independent review process into the incident has concluded allowing the trials to recommence, but only in the UK.

The University, which is working with pharmaceutical giant Astrazeneca, did not specify which day the UK trials would official resume. Astrazeneca is expected to continue working with health authorities around the World in order to get other clinical trials back on track.

Back To Top